Medtronic’s smartphone-connected device, MiniMed Connect, is now available in the U.S, the company has announced.

Working in tandem with a companion app, said device enables people with diabetes to conveniently view their insulin pump and continuous glucose monitoring (CGM) information on a smartphone. Moreover, it also provides a greater peace of mind for their care partners, and more convenient access to diabetes data for healthcare teams.

The last mentioned capability is delivered through CareLink Personal, Medtronic’s therapy management software that can deliver preset text notifications to care partners when the person with diabetes experiences sugar levels that go too high or too low or when an alarm on the pump isn’t cleared.

MiniMed Connect sings along the MiniMed 530G system and MiniMed Revel systems, while the companion app is initially available for iPhone users, only. As part of its strategic tie-up with Samsung, Medtronic is working on an Android app.

MiniMed Connect also provides a greater peace of mind for their care partners, and more convenient access to diabetes data for healthcare teams.“Effective management of diabetes requires an engaged team of participants, and MiniMed Connect serves to inform and involve people with diabetes, their loved ones and their health care professionals,” said Annette Bruls, President of the Diabetes Service and Solutions business at Medtronic. “Safe and secure sharing of critical diabetes data is an important step for Medtronic as we transform into a holistic diabetes management company.”

Medtronic’s diabetes management division is moving beyond insulin pumps and CGM devices and integrating novel technologies, data and informatics to enable better therapy decision-making and care.